Systematic review / meta-analysis / 2016
Global prevalence of nonalcoholic fatty liver disease was estimated at 25 percent.
A meta-analysis of 86 studies encompassing 8,515,431 individuals across 22 countries assessed nonalcoholic fatty liver disease epidemiology. Global prevalence was 25.24% (95% CI: 22.10-28.65), with frequent comorbidities including obesity (51.34%) and type 2 diabetes (22.51%). Annual liver-specific mortality was 0.77 per 1,000 person-years in nonalcoholic fatty liver disease and 15.44 per 1,000 in nonalcoholic steatohepatitis.
- Study type
- Meta-analysis
- Who was studied
- 8,515,431 participants across 86 studies from 22 countries
- What was measured
- Prevalence, incidence, progression, and mortality of NAFLD and NASH
THE PAPER
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Hepatology, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.